$ACB Target 14.72 for 27.67% $ACB Target 14.72 for 27.67%
Or next add level is at 8.34
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible.
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed.
GL and happy trading.
ACB
BullishRSI seems to have bottomed out.
MACD has a triple cross to the upside on the shorter time frame.
Possible reverse head & shoulders reversal formation forming, but we would need a break above $19.20 to really play that out.
Also it made me laugh that a hedge fund is posting negative articles about this. I think they're just trying to get in to blow it up.
Please don't waste more time or money. ...ACB
Hello, I did this analysis because I am losing 50% of my entire portfolio at the moment with ACB, my opinion is that ACB has no future. its graph is very bad. it is very sensitive to financial markets. freaks out over very little things or nothing.
Every resistance breaks it no matter what happens. The last time one day before the earnigs reports hit the bearish resistance and fell back. Edge funds knew about this and they put massive short orders just like they did with GME now they break every support or resistance, no matter how good the news is, it always ends up falling.
Financially, ACB is the worst company among all in its sector. It has the largest debt of all and each time its net profits are smaller, also the money is spent to acquire more things when the business does not even have a profit. smaller and smaller earnings.
growing debt. Financially it is rubbish.
I hope people can get out of this company as quickly as they can and don't lose all their money. have a good day
EDEN - Eden Empire - Cannabis Stock EDEN or EDEN.CN on the CSE (Canadian Stock Exchange) is a new recently listed cannabis stock that is a chain of dispensaries across the U.S and Canada. They also have growing facilities, cannabis cultivation and extraction facilities. They are going to have continued expansion, and have an outlook of $1.00 by the end of the year!
Ready or not here we go!!!So Tilray has it all, fundamentals..yes i just got the literature, healthy read, from the merger with apha and its looking fantasmagoric.
The industry is heating up globaly. Canadian cannabis sector on full boom and consolidation cicle..oportunity everywhere
I would thread carefully as always, cause this is a volatile industry..treat as day trade always.
Be ready to cal lin the sale afterhours or pre market...if you are fe..eling overnighty..
goodluck
\Just a thought
DO OR DIE IISector wide pattern, bottom of the channel, burst of volume in short timeframes. Wait for confirmation break above resistance and trail stop every resistance on the way up, it breaks support its a gonner, carefull...
No the best company, carefull.
Once it gets going , its dificult to stop the momentum on this stock.
ACB - LONGA cannabis Stock got good potential. I am looking at a bounce back at 8.90s if everything goes according to my theory. Would probably enter at 9-9.1. Leave your thoughts in the comments.
NOT FINANCIAL ADVICE!!!!
Buy $ACB - NRPicks 28 FebAurora Cannabis Inc. produces and distributes medical cannabis products around the world. It is vertically integrated and horizontally diversified in various segments of the cannabis value chain, including facility engineering and design, cannabis cultivation, genetic research, production, derivatives, high value-added product development, domestic cultivation, wholesale and retail distribution.
Technical:
Low RSI Levels - Oversold
Below MA50
MACD Level (12, 26) 0.39
1st Fibonacci retracement target
Aurora looks at an improvement in EBITDA for the third quarter after reductions to its number of employees a few months ago. Cost cutting.
Reduced its operating expenses by 6.6% quarterly
$ACB Target 15.95 for 25.00% - or next add level at 9.57$ACB Target 15.95 for 25.00%
Or next add at 9.57
I am not your financial advisor. My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you.
GL
Time to get high? really high???I always try to present the charts in a simple comprehensive format to prevent any confusion.
This is just my technical view, neither a fundamental comment nor a recommendation to trade..!
Please review my track record and calculate the odds for yourself..!
You’re likes and comments encourage me to continue this.
Stay tuned great live stream and quality content videos coming soon..!
ACB CorrectiveShe took the proposed bearish alternative path. Announced a new shelf prospectus of $1B yesterday. If $8.14 is lost, the previously proposed bullish alternative will be invalid.
$1B shelf prospectus. Does that suggest that they are looking to make investments? The amount seems rather high, considering they already had a new prospectus for $300M.
The Week Ahead: WKHS, TLRY, NKLA, ACB, MJ, TAN, ICLN, IWMI'm doing a quick and dirty this week just to give me a sense of where premium is at ... .
Highly Liquid Single Name With Earnings in the Rear View Ranked by 30-Day Implied Volatility:
WKHS (27/232) (EV)
TLRY (13/193) (Cannabis)
NKLA (15/138) (EV)
ACB (6/124) (Cannabis)
SPCE (30/120) (Aerospace)
PLUG (39/113) (Alternative Energy)
NIO (41/107) (EV)
TEVA (11/103) (Pharmaceuticals)
TSLA (30/103) (EV, Alternative Energy)
NCLH (6/95) (Cruise Lines)
Highly Liquid Exchange-Traded Funds Ranked by 30-Day Implied Volatility:
MJ (39/76) (Cannbais)
TAN (47/71) (Solar)
ICLN (10/56) Alternative Energy)
KRE (9/54) (Regional Banking)
LIT (41/53) (Alternative Energy)
JETS (41/53) (Airlines)
SMH (21/46) (Semiconductor)
EWZ (7/46) (Brazil)
XLE (3/46) (Energy)
XBI (27/45) (Biopharma)
Highly Liquid Broad Market Exchange-Traded Funds Ranked by 30-Day Implied Volatility:
IWM (13/35) (Russell 2000)
QQQ (13/32) (Nasdaq)
SPY (8/24) (S&P 500)
DIA (3/22) (Dow Jones)
EFA (6/19) (Global Equity, ex. Canada/U.S.).
Not feeling Aurora. Looking for Head and Shoulders reversalThey were left out of the deal with Aphria, lost a CEO last year who was hired particularly to find a merger/acquisition, they have been continuing layoffs, lost billions of dollars last year, keep diluting the stock, and they are running a large multinational organization (complicated).
The best hope for ACB is that it has hit rock bottom as a company and will survive with nowhere to go but up.
Watch for these moves to see which way it is heading.
Yellow line through a green zone is a potential buy,
Red line through a red zone is a potential sell.
Always check fundamentals/technicals before making any trade.
Might be able to add 1/2 here..see what it looks like @ PHPH (power hour). Just wanted a quick headline with the view.
It's almost like you can just feel the stupidity..It's hard to explain, I don't know how, but it's almost like you can just feel the stupidity permeating from this chart pattern...
It's like art, really..Wallstreetbets has truly outdone itself this time.
Companies Selling Stock Were Outperforming The Nasdaq By 40%ZeroHedge, Wed, 08/26/2020 - 10:05
"2020 has been a stunning year for countless reasons, and one of them as we previously reported is that following the covid pandemic there was an absolute avalanche of equity offerings, culminating with some $113 billion in stock sales in the second quarter as we showed before.
"Yet while the staggering amount of follow-on offerings is not news, the performance of companies selling their stock is nothing short of shocking, because whereas in a normal world the association dilution with new equity sales would in theory result in depressed stock prices, the reality of the past few months has been anything but.
First, a quick update on equity offerings as of late August.
As Bloomberg notes today, a new milestone in secondary offerings shows the power of this year’s unique market in bringing together sellers and buyers. Issuers and their largest holders have now priced 783 secondary offerings on U.S. exchanges this year, with the total surpassing 2019’s full-year total of 780 on Monday.
In terms of cash proceeds, the $169 billion raised in this year’s secondaries is already the most for a full calendar year since 2015. And unlike the surge in IPOs, which has been driven largely by special purposes acquisition companies, Bloomberg notes that these secondary offerings are being conducted in real businesses.
Two main factors deserve the credit for this years-high in deal flow. On the sell side, companies found themselves scrambling to cover cash needs, while a pandemic spoiled expectations for revenue. On the buy side, traders kept coming back for more after recent deals shocking outperformed the broader market.
And here is the punchline: stocks sold in 2020 secondary offerings closed on Tuesday 39% above their offering price on average. That’s outpacing the year’s 28% gain in the Nasdaq Composite Index, a 40% outperformance.
There's more: the performance of July’s 98 secondaries, which closed Tuesday an average of 278% above their offering price, serves as a recent and major source of excitement for more paper in the market. Indeed, if investors are clamoring for public companies to sell their stock and raise cash, which company in its right mind would say no?
As Bloomberg concludes, while the pace of deals is now slowing heading into a traditional vacation period for equity capital markets, bankers are optimistic that the final four months of 2020 continue to serve as fertile grounds for even more secondary offerings."
"Companies raised more money through stock market listings in 2020 than in any year besides 2007", FT
"Companies raised more money through stock market listings in 2020 than in any year besides 2007, as a rebound in equities valuations lured in businesses and blank-cheque acquisition vehicles rushed to list in the US.
Businesses raised almost $300bn through flotations globally in 2020, including a record $159bn in the US, according to data provider Refinitiv. The boom included the public debuts of high-flying tech businesses such as DoorDash and Airbnb, as well as listings for groups that seek to buy others and fast-track them on to public markets."
Aurora Cannabis Great Risk Reward SetupACB has a well defined ascending trend line supporting the price which the price just bounced off of. The upper trend line is not as well defined, but I copy and pasted the bottom trend line in the assumption that ACB is in somewhat of a parallel channel with some fake-outs above. Regardless of the channel, there is resistance around ~$18 that the price has fallen from a few times. This $18 level has also been used as support in the past.
With the pivot that ACB recently put in, there is a point to measure risk. With a stop below that point and a target of around $18, the risk reward ratio is about 3.
ACB Falling WedgeQuick update to previous proposed dual count. Falling wedge in play, seems to favour the bull count.
Not surprisingly, a break out here would target the proposed upper range.
Lotto Ticket Play, Highly ManipulatedJust something I remembered from a few years back. Love that tradingview play button, so figured I'd post the look just to see what will happen. Noticed it was moving.
Back in 2018, for awhile it was the darling of speculatives in the weed stock sector, rising from sub $1.00 to $15.00. That was back when TLRY blew up the stock market.
They recently entered into a deal with Benchmark for a $75,000,000 ATM offering. Again, there's probably much better plays out there; just posting the view -- not really bullish or bearish..
Cheers and good luck.
